Paget Paget
Paget Paget
  Educational Slide Program  
 

  43  
Tiludronate Disodium ( Skelid® )  
 
<< Back  
  This illustrates the effect of 200 or 400 mg/day tiludronate given for 12 weeks to patients with Paget's disease whose serum alkaline phosphatase activity was at least twice the upper limit of normal. The serum alkaline phosphatase activity was reduced by 58% at 24 weeks by the 400 mg dose.

Source: McClung; MR et al, Bone 17, #5, Supplement 1995: 4935.
 
 
    Previous Image | Next Image